Growth Metrics

Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -30.90%
Dec 31, 2025 35.56%
Sep 30, 2025 -82.26%
Jun 30, 2025 340.90%
Mar 31, 2025 -27.88%
Dec 31, 2024 10.34%
Sep 30, 2024 18.27%
Jun 30, 2024 54.85%
Mar 31, 2024 -12.21%
Dec 31, 2023 -14.82%
Sep 30, 2023 16.05%
Jun 30, 2023 2.26%
Mar 31, 2023 -20.20%
Dec 31, 2022 -17.59%
Sep 30, 2022 -5.60%
Jun 30, 2022 -8.44%
Mar 31, 2022 -50.57%
Dec 31, 2021 43.92%
Sep 30, 2021 -44.04%
Jun 30, 2021 205.00%
Mar 31, 2021 -3.35%
Dec 31, 2020 96.92%
Sep 30, 2020 -40.83%
Jun 30, 2020 -41.04%
Mar 31, 2020 13.80%
Dec 31, 2019 6.52%
Sep 30, 2019 140.00%
Jun 30, 2019 -36.72%
Mar 31, 2019 -35.76%
Dec 31, 2018 14.55%
Sep 30, 2018 -6.05%
Jun 30, 2018 1.75%
Mar 31, 2018 -1.05%
Dec 31, 2017 -1.11%
Sep 30, 2017 -11.11%
Jun 30, 2017 77.52%
Dec 31, 2015 -72.02%
Sep 30, 2015 82.33%
Jun 30, 2015 173.03%
Mar 31, 2015 17.99%
Dec 31, 2014 90.83%
Sep 30, 2014 -8.92%
Jun 30, 2014 35.87%
Mar 31, 2014 -1.41%
Dec 31, 2013 -17.08%
Sep 30, 2013 45.04%
Jun 30, 2013 6.12%
Mar 31, 2013 3.45%
Dec 31, 2012 -28.53%
Sep 30, 2012 127.74%
Jun 30, 2012 291.36%
Mar 31, 2012 141.43%
Dec 31, 2011 66.64%
Sep 30, 2011 3.42%
Jun 30, 2011 -35.26%
Mar 31, 2011 -111.99%
Dec 31, 2010 63.82%
Sep 30, 2010 -41.82%
Jun 30, 2010 26.90%
Mar 31, 2010 38.26%
Dec 31, 2009 -909.97%